"Nitriles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE.
| Descriptor ID |
D009570
|
| MeSH Number(s) |
D02.626
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitriles".
Below are MeSH descriptors whose meaning is more specific than "Nitriles".
This graph shows the total number of publications written about "Nitriles" by people in this website by year, and whether "Nitriles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 1 | 3 |
| 2004 | 1 | 5 | 6 |
| 2005 | 3 | 3 | 6 |
| 2006 | 0 | 2 | 2 |
| 2007 | 2 | 1 | 3 |
| 2008 | 1 | 5 | 6 |
| 2010 | 1 | 2 | 3 |
| 2011 | 2 | 4 | 6 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 5 | 6 |
| 2014 | 1 | 3 | 4 |
| 2015 | 0 | 3 | 3 |
| 2016 | 1 | 3 | 4 |
| 2017 | 4 | 8 | 12 |
| 2018 | 0 | 5 | 5 |
| 2019 | 1 | 3 | 4 |
| 2020 | 4 | 7 | 11 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 3 | 3 |
| 2023 | 0 | 4 | 4 |
| 2024 | 10 | 4 | 14 |
| 2025 | 0 | 2 | 2 |
| 2026 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nitriles" by people in Profiles.
-
Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea. Blood. 2026 May 07; 147(19):2215-2225.
-
Senolytic-Resistant Senescent Cells Have a Distinct SASP Profile and Functional Impact: The Path to Developing Senosensitizers. Aging Cell. 2026 01; 25(1):e70358.
-
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm. Bone Marrow Transplant. 2026 03; 61(3):333-340.
-
Preclinical efficacy of CDK7 inhibitor-based combinations against myeloproliferative neoplasms transformed to AML. Blood. 2025 02 06; 145(6):612-624.
-
Co-targeting of the thymic stromal lymphopoietin receptor to decrease immunotherapeutic resistance in CRLF2-rearranged Ph-like and Down syndrome acute lymphoblastic leukemia. Leukemia. 2025 03; 39(3):555-567.
-
Environmental exposure to common pesticide induces synaptic deficit and social memory impairment driven by neurodevelopmental vulnerability of hippocampal parvalbumin interneurons. J Hazard Mater. 2025 03 05; 485:136893.
-
Trends in novel antiandrogen receptor signal inhibitor use and medical costs in prostate cancer. Cancer Med. 2024 Dec; 13(24):e70226.
-
Correlation of Body Mass Index with Overall Survival Among Patients with Metastatic Hormone-sensitive Prostate Cancer: Analysis of Patient-level Data from SWOG-1216. Eur Urol Oncol. 2025 Jun; 8(3):612-615.
-
Can Ruxolitinib Crash TET2- and IDH2-Driven Clonal Hematopoiesis? Cancer Discov. 2024 Oct 04; 14(10):1768-1770.
-
Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study. Int J Hematol. 2024 Dec; 120(6):705-716.